Weston Brain Institute International Outstanding Achievement Award 2018

Submit A Nomination

Sign in to our online system or register for a new account to submit a nomination.

Apply Now

The Weston Brain Institute supports research that accelerates the development of therapeutics for neurodegenerative diseases of aging.  To help achieve this, the Institute addresses gaps and inefficiencies in the funding market by supporting high-risk, high-reward translational projects, while leveraging world-class business and scientific expertise in a fast and flexible granting process.

Ensuring the world hears about scientific advances in a timely manner is also critical to accelerating treatments.  The Weston Brain Institute International Outstanding Achievement Award was created to recognize and highlight the recent outstanding contributions of researchers to the global effort to fight these diseases.

The award is presented once a year, and nominee eligibility alternates between Canadian-based researchers and those based in Ireland, the Netherlands and the UK.

Past awardees include Dr. Peter St George-Hyslop (2016, Canada), and Professor Nick Fox (2017, UK).

2018 Award

In 2018, the award will be honouring a Canadian-based researcher for recent contributions in translational research in neurodegenerative diseases of aging.

The award consists of a $40,000 prize provided to the awardee through a Canada Revenue Agency qualified donee institution with which the awardee is affiliated.

The award will be presented at a ceremony concurrent with the Society for Neuroscience Annual Meeting in San Diego, California in November 2018.

Nominations close:          Tuesday, June 12, 2018 – 2 pm EDT

Award announcement:   November 2018

*Dates may change


Nominator: Anyone located anywhere can submit one or more nominations for the award.  Self-nominations are not permitted.

The award offers the unique opportunity to support research excellence and to celebrate exceptional achievements by Canadian-based researchers in neurodegenerative diseases of aging.  Submit your nomination.

Nominee: To be eligible, the nominee must:

  • Have made exceptional contributions in translational research that have accelerated the development of therapeutics for neurodegenerative diseases of ageing, in particular in the past 15 years. Please note that this is NOT a lifetime achievement award.
  • Be presently leading translational research on neurodegenerative diseases of ageing with a current full-time appointment/position, and have an appointment at a Canada Revenue Agency qualified done institution in Canada.
  • Be working in Canada >50% of the time at or above the assistant professor or equivalent level.
  • Have performed >50% of relevant research and leadership contributions in the past 15 years in Canada.
  • Have positive recommendations for citizenship in the research community and societal contributions.

The following are not eligible:

  • Those who have retired/have Emeritus status.
  • Those who do not anticipate having a full-time position in research for the next 5 years.
  • Those who will not likely be engaged in translational research to accelerate the development of therapeutics for neurodegenerative diseases of ageing for the next 5 years.
  • Past recipients of this award.
  • Self-nominations.

Institute definitions:

Neurodegenerative diseases of ageing:

  • Alzheimer’s disease
  • Dementia with Lewy bodies
  • Frontotemporal dementia
  • Multiple system atrophy
  • Parkinson’s disease
  • Progressive supranuclear palsy
  • Vascular contributions to the above diseases (not stroke-mediated vascular disease)
  • Prodromes to the listed diseases, including
    • Mild cognitive impairment as prodromal to Alzheimer’s disease
    • REM sleep behaviour disorder as prodromal to Parkinson’s disease

Please refer to our Funding Overview page for other relevant Institute definitions.

Evaluation Criteria

Nominees that meet all eligibility requirements will be reviewed by the award jury. The following criteria will be used to evaluate applications for this program:

  • Research contributions (weight – 75%): The nominee must have accelerated the development of therapeutics for neurodegenerative diseases of ageing through exceptional contributions to translational research.  In the selection process, greater emphasis (weight – 70%) will be placed on contributions that have occurred in the past 15 years.  Contributions that occurred more than 15 years ago and the potential of a nominee’s future work will also be taken into account in the overall score for ‘Research contributions’ (weight – 15% each for past and future contributions).
  • Leadership contributions (weight – 25%): The nominee must have a record of exceptional leadership in translational research for accelerating the development of therapeutics for neurodegenerative diseases of ageing.

A nominee’s societal contributions and citizenship will be taken into account if all else (i.e., scientific and leadership contributions) is considered equal among the top candidates.

Please refer to the Program Details for complete information on evaluation criteria.

Application Process

All nominations must be submitted through our online system by Tuesday, June 12, 2018.

Refer to the Sample Application for the list of questions asked in the nomination form.

Once a nomination has been submitted by the nominator, the Institute will contact the nominee for additional supporting information (including curriculum vitae, two optional letters of reference and a standard release form).

Completed applications (nomination form, CV, up to two reference letters, release form) submitted no later than Wednesday, June 27, 2018, will be prescreened for eligibility and then reviewed by the Institute’s award jury.

Further Information

For further information about the award, please refer to the following:

Program Details

Sample Application

Request for Applications – download a printable version


The Institute welcomes additional inquiries about this award. Please contact Cristina Tang at cristina.tang@weston.ca or +1 416-935-5356.